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Available online 12 July 2017AbstractPurpose: To test the hypothesis that macular choroidal thickness is lower in patients with pseudoexfoliation syndrome (PXS) as compared to
healthy control subjects.
Methods: In this cross-sectional, observational study, 38 non-glaucomatous PXS subjects and 37 healthy volunteers were enrolled in a tertiary
care Glaucoma Clinic. The macular region was scanned with the enhanced depth imaging (EDI) protocol of a spectral domain optical coherence
tomography (SD-OCT) device (Spectralis OCT, Heidelberg Engineering, Heidelberg, Germany). Macular choroidal thickness and volumes were
compared in nine sectors of the Early Treatment Diabetic Retinopathy Study (ETDRS) layout profile across the central 3.45 mm zone after
manual segmentation of the choroidal thickness. Linear mixed modeling was used to adjust for confounding variables.
Results: Six PXS eyes and 8 control eyes were excluded due to poor image quality leaving 32 PXS and 29 control eyes for final analyses. The
average age and axial length of the PXS and control groups were 67.94 ± 7.30 vs 64.86 ± 7.04 and 22.91 ± 0.77 vs 23.24 ± 0.66 mm,
respectively, (P ¼ 0.10 and 0.20). There was no significant difference in retinal nerve fiber layer (RNFL) thickness between the two groups
(P ¼ 0.24). The choroidal thickness was significantly lower in the central subfield subfoveal area (P ¼ 0.02) and in the inner superior (P ¼ 0.03)
and inner nasal quadrants (P ¼ 0.03) in the PXS group compared to the control group, as was the choroidal volume (P ¼ 0.02). No significant
difference was found in macular choroidal thickness after adjusting for age, gender, and axial length. While there was a significant negative
association between age and central subfield choroidal thickness in the control group (r ¼ 0.48, P ¼ 0.01), this association was not significant
in the PXS group (r ¼ 0.08, P ¼ 0.68).
Conclusions: Our findings demonstrate that the choroid does not seem to be significantly altered in PXS eyes. Choroidal thickness changes need
to be explored in PXS eyes with glaucoma.
Copyright © 2017, Iranian Society of Ophthalmology. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Pseudoexfoliation syndrome (PXS) is a common age-
related genetic disorder with a probable environmental
component affecting intraocular and extraocular tissues.1,2 A
significant proportion of patients with PXS can develop
glaucomatous damage that has higher intraocular pressure
(IOP) and more severe fluctuation in IOP compared with
primary open-angle glaucoma (POAG), revealing this type of
glaucoma to have faster progression and poorer prognosis than
POAG.3e5 It has been shown that at a given level of IOP, the
probability of having optic nerve damage was higher in eyes
with pseudoexfoliation.6 The presence of PXS has been shown
to be the most important independent risk factor for progres-
sion of glaucoma in the Early Manifest Glaucoma Trial.7 Also,
it has been shown that the glaucoma conversion rate was twice
as high in patients with both ocular hypertension and pseu-
doexfoliation as in control ocular hypertension patients
matched for IOP, age, and gender.8 It seems that factors other
than IOP level contribute to the putting puzzle pieces into a
coherent picture of PXS pathogenesis.9
Given the role of the choroidal vasculature in the blood
supply of the laminar and prelaminar regions of the optic
nerve head (ONH), the choroid might be a relevant target for
investigation in glaucomatous patients.10,11 Enhanced depth
imaging (EDI) is a newly emerging technique that enables
capturing high resolution images of the deep structures of the
posterior segment, minimizing the light scattering that is
encountered in regular spectral domain optical coherence to-
mography (SD-OCT) imaging. This technology has been used
widely in evaluating of lamina cribrosa and choroid in glau-
comatous eyes and revealed that these structures might be
thinner in some types of glaucoma.12,13
In this study, our goal was to compare macular choroidal
thickness in non-glaucomatous pseudoexfoliative patients to
normal eyes using the EDI function on the SD-OCT.
MethodsPatientsIn a cross-sectional design, 38 consecutive patients with
PXS whose diagnosis was established or confirmed at the
Glaucoma Clinic of Farabi Eye Hospital as well as 37 normal
volunteers who were examined for refractive error were
enrolled. This is an extension of our previous report on
peripapillary retinal nerve fiber layer (RNFL) and ONH pa-
rameters in PXS patients.14 When both eyes of the patient
met the eligibility criteria, only one eye was chosen for in-
clusion randomly. All subjects underwent a comprehensive
eye examination, including measurement of best corrected
visual acuity, slit-lamp biomicroscopy, Goldmann applana-
tion tonometry, gonioscopy, dilated stereoscopic fundus ex-
amination using a 90 or 78 diopter (D) lens, measurement of
the central corneal thickness (CCT) by pachymetry (Tomey
Corporation, Nagoya, Japan), standard white on white visual
field [Humphrey Field Analyzer (HFA) II 750; 24-2 Swedishinteractive threshold algorithm; Carl Zeiss Meditec, Dublin,
CA], ocular biometry (IOLMaster; Carl Zeiss Meditec).
ONH and macula (Spectralis OCT, Heidelberg Engineering,
Inc., Dossenheim, Germany). Subjects also underwent ONH
and macular imaging with EDI SD-OCT (Specteralis,
HEYEX software 6.0 Heidelberg Engineering, Heidelberg,
Jena, Germany). The inclusion criteria were as follows: 1)
best corrected visual acuity of 20/40 or better with spherical
equivalent within 5 D of emmetropia and cylinder correction
within 3 D. 2) IOP < 22 mmHg; Exclusion criteria included:
1) any other neurologic disorders that could lead to visual
field defect; 2) any history of previous ocular surgery,
consistently unreliable visual fields (defined as false negative
>20%; false positive >15%, and fixation losses >20%); 3)
glaucoma diagnosis; or 4) history of diabetes mellitus; or 5)
significant media opacity.
The normal control group had an IOP < 22 mmHg, no
history of increased IOP, normal disc appearance, and a
normal visual field. Absence of the glaucomatous disc
appearance was characterized as an intact neuroretinal rim
without cupping, notches, or localized pallor. The patients
were enrolled into the PXS group if they demonstrated visible
pseudoexfoliation material on the anterior lens capsule or
pupillary margin after mydriasis on slit-lamp biomicroscopy
and had 1) IOP less than 22 mmHg with no history of
increased IOP, 2) normal optic disc head, and 3) normal visual
field.
The study was conducted in accordance with the tenets of
the Declaration of Helsinki. The Ethics Committee of Farabi
Eye Hospital approved the study protocol and written
informed was provided for all the subjects prior to enrollment.Spectral domain optical coherence tomographyAll OCT measurements were performed using SD-OCT
(Heidelberg Spectralis SD-OCT; Heidelberg Engineering;
Spectralis software version 5.3.2) after pupillary dilation.
Scans with quality score of less than 20 were excluded from
the analysis. We also excluded scans with inadequate quality
as determined by poor quality fundus images, interruption of
the RNFL segmentation, or those in which the posterior border
of the choroid could not be delineated (Fig. 1).Enhanced depth imaging spectral domain optical
coherence tomography of the macular choroidUsing the Raster protocol (23 sections, each consisting of
100 averaged scans) images were obtained in a 20  30
rectangle centered on the fovea. The EDI images were viewed
and measured with the Heidelberg Eye Explorer software
(HEYEX™ Heidelberg Engineering, Dossenheim, Germany).
The choroid was manually outlined for all 23 lines, with the
anterior border at the basal aspect of retinal pigment epithe-
lium and the posterior boundary (choroidoscleral interface) as
a hyper-reflective line between the large vessel layer of the
choroid and the sclera. Choroidal maps and volumes were
measured in nine sectors of the ETDRS layout profile across
Fig. 1. An optical coherence tomography (OCT) image shows the manual segmentation of Bruch's membrane (upper red line) and sclerochoroidal border (lower red
line) in a raster line of macula. Choroidal map and volume measured in nine sectors of the Early Treatment Diabetic Retinopathy Study (ETDRS) layout profile
across the central 3.45 mm zone in the macula after manual segmentation of choroidal thickness.
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mentation of the choroidal thickness (Fig. 1).
To evaluate the intra-observer and inter-observer repro-
ducibility of choroidal thickness measurements, 15 EDI-OCT
macular scans were selected and analyzed by 2 independent
observers. Intraclass correlation coefficients (ICC) for the
measurement conducted by the two observers were calculated
using a two-way mixed effect model and demonstrated
excellent values for sectoral and average choroidal thickness
or volume (range, 0.962e0.999).Statistical analysisSPSS software (version 18 for Windows; SPSS Inc., Chi-
cago, IL, USA) was used for analyzing the data. Student t-test
or ManneWhitney U test were performed for comparisons of
parametric and non-parametric continuous variables, respec-
tively. Chi-square test was used for comparing categorical
variables. Linear mixed modeling was used to adjust the
choroidal thickness for age, sex, and axial length, and to ac-
count for the effect of confounders. Pearson correlation anal-
ysis was done to assess any correlation between the main
choroidal parameters (central subfield choroidal thickness,
choroidal volume) in each group. A P-value less than 0.05 was
considered statistically significant.Results
Of 38 PXS participants and 37 controls who met inclusion
criteria, 6 (16%) PXS participants and 8 (21%) of the control
eyes, were excluded because of unqualified image, and 32
pseudoexfoliation and 29 control eyes were included for final
analysis. The control group comprised 13 male and 16 female
patients, with a mean age of 64.8 ± 7.0 years, which was not
significantly different from PXS group which included 20
male and 12 female with a mean age of 67.9 ± 7.3 years.
(P ¼ 0.10 and P ¼ 0.52, respectively.) There was no signifi-
cant differences in refractive error (0.09 ± 0.92 vs. 0.17 ± 0.86
D), IOP (14.55 ± 2.33 vs. 15.20 ± 2.67 mmHg), CCT
(496.88 ± 62.51 vs. 516.96 ± 30.63 mm) and axial length
(23.24 ± 0.66 vs. 22.91 ± 0.77) between control and PXS eyes
(P ¼ 0.43, P ¼ 0.32, P ¼ 0.38, P ¼ 0.20, and l ¼ 0.22,
respectively).
RNFL thickness was not statistically significant different
between the PXS and control eyes (Table 1). The central
subfield choroidal thickness, the choroidal thickness in the
superior and nasal quadrants of inner rings (3 mm), and even
though choroidal volume was significantly less in the PXS
group but not after adjustment for age and axial length
(Table 2).
Table 2
Comparison of macular choroidal thickness between pseudoexfoliation and control groups with and without adjustment for age, sex and axial length.
Control group (Mean ± SD) Pseudoexfoliation group P-value Adjusted P-value
Choroidal volume (mm3) 7.79 ± 1.40 6.73 ± 2.04 0.02 0.16
Central subfield choroidal thickness (mm) 310.7 ± 57.5 270.8 ± 76.9 0.02 0.36
Inner ring (Superior) (mm) 311.2 ± 50.74 274.1 ± 75.14 0.03 0.32
Inner ring (Nasal) (mm) 301.8 ± 56.6 264.5 ± 71.46 0.03 0.36
Inner ring (Inferior) (mm) 299.3 ± 59.42 267.1 ± 70.71 0.06 0.37
Inner ring (Temporal) (mm) 284.2 ± 57.35 259.7 ± 73.86 0.15 0.39
Outer ring (Superior) (mm) 293.5 ± 51.32 261.4 ± 72.87 0.05 0.31
Outer ring (Nasal) (mm) 259.1 ± 53.12 235.5 ± 67.87 0.14 0.71
Outer ring (Inferior) (mm) 278.2 ± 58.01 251.9 ± 70.01 0.12 0.55
Outer ring (temporal) (mm) 237.4 ± 56.60 230.5 ± 76.94 0.69 0.84
Inferotemporal (mm) 145.63 ± 53.10 156.94 ± 65.14 0.56 0.40
P values less than 0.05 are shown in bold.
Table 1
Retinal nerve fiber layer (RNFL) thickness comparison between the two groups with and without adjustment for age, sex, and axial length.
RNFL Control group (Mean ± SD) Pseudoexfoliation group (Mean ± SD) P-value Adjusted P-value
Global retinal nerve fiber layer (mm) 99.6 ± 12.6 93.1 ± 7.0 0.05 0.24
Temporal retinal nerve fiber layer (mm) 64.0 ± 13.8 61.8 ± 13.1 0.58 0.49
Superotemporal retinal nerve fiber layer (mm) 131.4 ± 19.6 122.6 ± 18.0 0.14 0.20
Superonasal retinal nerve fiber layer (mm) 114.5 ± 23.4 102.7 ± 18.7 0.07 0.11
Nasal retinal nerve fiber layer (mm) 78.3 ± 12.3 77.6 ± 9.9 0.85 0.76
Inferonasal retinal nerve fiber layer (mm) 125.4 ± 28.0 122.3 ± 21.7 0.68 0.40
Inferotemporal retinal nerve fiber layer (mm) 141.1 ± 24.20 121.7 ± 27.0 0.07 0.44
RNFL: Retinal nerve fiber layer.
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age and central subfield choroidal thickness in the control eyes
(r ¼ 0.48, P ¼ 0.01), this association was not significant in
the PXS eyes (r ¼ 0.08, P ¼ 0.68). Similarly, we observed a
significant correlation between age and choroidal volume in
the control group (r ¼ 0.46, P ¼ 0.01). However, there was
no significant association between age and choroidal volume
in the PXS group (r ¼ 0.09, P ¼ 0.63) (Fig. 2). We also did not
find any correlation between CCT, global RNFL thickness,
and choroidal thickness in either PXS eyes or control eyes.
Discussion
Recent evidence suggests that greater IOP fluctuation itself
may not completely explain the poorer prognosis of PXG
compared to POAG, making the dilemma of the pathogenesis
of PXG like a puzzle with unrecognized pieces.7 It seems that
PXS may be an independent risk factor for glaucomatous optic
nerve damage.15 In this study, we evaluated the role of macular
choroid as the one of possible pieces of the puzzle using EDI-
SDOCT, and we found that the thickness of macular choroid is
not significantly different from normal subjects.
The choroid might apply its effects through its nutritional
and vascular support of the ONH. In addition, choroidal vol-
ume and its expansion throughout the day may exert an
important effect on the trabecular outflow facility. Dayanir
et al., have observed significant changes in ophthalmic artery
hemodynamic parameters in both eyes of unilateral PXS pa-
tients, illustrating the systemic nature of the disease.16 WhileMaul et al have found a significantly thinner macular choroid
in glaucoma patients than in glaucoma suspects, this differ-
ence was not significant when adjusted for other parameters in
a multivariable model.17 In another study by Hosseini et al.,
investigating 43 POAG patients and 20 controls, no difference
was observed in choroidal thickness in POAG eyes compared
to normal eyes after adjusting for age and axial length.18
While Park et al. did not observe significant differences in
choroidal thickness in patients with POAG compared to con-
trols, peripapillary choroidal thickness was thinner in normal
tension glaucoma eyes than in controls.19 In another two se-
ries, the authors found a significantly thinner choroid in PXS
patients compared to controls.20 In our study, we found a
significantly lower macular choroidal thickness in the PXS
group compared to the control group. However, when we
adjusted our result for age and axial lengths of patients, there
was no longer a significant difference in macular choroidal
thickness between PXS eyes and controls. Recently, Turan-
Vural et al. evaluated subfoveal choroidal thickness of 35
PXS eyes and 26 controls, and reported that PXS eyes might
have thinner subfoveal choroid.21 A reason for this discrep-
ancy might be that they did not adjust their choroidal mea-
surements for confounding factors including age and axial
length. Another study has been shown that peripapillary
choroid is not thinner in eyes with PXS syndrome.14 More-
over, a recent study by Ozge et al. has not shown that choroid
becomes thinner in exfoliative glaucoma compared to PXS
and normals.22 These studies suggest that the choroidal vol-
ume and thickness and its expansion during the different times
Fig. 2. Upper image: Scatterplot showing the correlation of age and macular choroidal volume in the control group. There was a negative correlation and choroidal
volume (r ¼ 0.46, P ¼ 0.01) and age in the control group. Lower image: Scatterplot showing the correlation of macular choroidal volume and age in the
pseudoexfoliation group. No correlation was found between age and choroidal volume (r ¼ 0.09, P ¼ 0.63) and age in the pseudoexfoliation group.
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damage in PXG.
In another study, Kocabeyoglu et al. found that choroidal
expansion during a water drinking test was not an important
mechanism for IOP elevation in healthy eyes or those with
PXS. Furthermore, given the similarity of IOP increase in PXS
and control eyes, authors suggested that trabecular outflow
facility is not impaired in eyes with PXS.23
In line with previous studies, we found that with increasing
age, the central subfield choroidal thickness, choroidal vol-
ume, and peripapillary choroidal thickness decreased in the
control group.14 However, we did not find a similar association
in our PXS group. Pseudoexfoliation may influence on effect
of age on choroidal thickness that leads to a non-significant
correlation of choroidal thickness and age.
This study had some limitations that should be kept in
mind. We have a small sample size, and the study may have
had potential selection bias as a result of patient exclusion due
to lacking image quality. Finally, although we included PXS
eyes with normal visual fields and IOP, it is still possible that
some of these eyes will be at the early stage of pseudoexfo-
liation glaucoma. However, the RNFL thickness was not
significantly thinner in PXS eye.
To summarize the main conclusions of this study, macular
and subfoveal choroidal thickness is not lower in eyes with
PXS compared to controls. Based on anatomical measure-
ments, the choroid does not seem to be significantly altered in
PXS eyes. Although age affects choroidal thickness in healthy
control eyes, we did not find any association of age and
choroidal thickness in PXS eyes.
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